Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1432.24	805.99	-52.60
Graham Fair Price	-87.38	0.23	1.86
PEG	42994.85	-2.57	< 0.005
Price/Book	-23.18	7.51	9.78
Price/Cash Flow	-711.52	-786.27	-96.89
Prices/Earnings	5010.95	260.71	-5.10
Price/Sales	-36.31	7.03	11.04
Price/FCF	-711.52	-786.27	-96.89
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	39.93	0.33	0.24
Operating Margin	84.45	-0.05	-0.34
ROA	-98.38	< 0.005	-0.06
ROE	-0.48	< 0.005	-98.50
ROIC	-0.05	-0.01	74.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.14	-0.02	-649.16
Dividends QOQ	-0.54	0.18	-65.72
EBIT QOQ	-4.23	0.81	-80.98
EPS QOQ	-8.56	1.02	-88.14
FCF QOQ	-1.48	0.90	-39.05
Revenue QOQ	-0.53	0.25	-52.40
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	124.69	89.45	-28.27
Days Sales Outstanding (DSO)	165.32	121.17	-26.71
Inventory Turnover	0.72	1.01	39.40
Debt/Capitalization	0.82	0.79	-3.65
Quick Ratio	0.39	0.40	2.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.57	0.58	2.91
Cash	0.54	0.57	5.67
Capex	-0.05	-0.07	-46.18
Free Cash Flow	-0.06	< 0.005	90.26
Revenue	0.50	0.62	24.13
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.55	0.54	-1.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.98	212.64	1421.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating